Product Code: PM4148
The global osteopontin market size is expected to reach USD 793.93 million by 2032, according to a new study by Polaris Market Research. The report "Osteopontin Market Share, Size, Trends, Industry Analysis Report, By Type (Human, Rat, Cow, Others); By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Osteopontin is a protein derived from cow's milk that can be used in infant formula and baby nutrition regimens and has undergone considerable phosphorylation. Manufacturers are coming up with new product formulations to create high-quality infant formulas that can be customized to treat a child's illnesses and satisfy other nutritional needs. Governments are supporting the products with osteopontin after checking their quality and effectiveness in curing.
According to parent company Health and Happiness Group (H&H Group), one of the main ingredients in the recently approved newborn formula by Biostime in China is lactopontin (LPN), also known as osteopontin from the cow's milk. This is demonstrating the rise in further research activities about osteopontin, fueling its expansion in the coming years. Manufacturing companies are investing time and funds to create new products with a higher nutritional profile, like breast milk, which has osteopontin as a major ingredient.
Osteopontin has gained traction in recent days owing to its higher nutritional content and its ability to treat various health difficulties in humans. It is believed that the milk protein osteopontin contributes to the development of the immune system, healthy bones, and teeth. Growing research and development activities to determine the benefits of osteopontin and its effectiveness in treating health care issues are driving the demand for this protein in the coming years. According to the study, which was published in the journal Nature in 2023, osteopontin & CD44 molecules are crucial for triggering hair growth. This revelation from the study will further create new growth opportunities for the osteopontin market by fueling research activities to innovate new products in the marketplace.
Growing osteoporosis is driving further research activities to create effective therapies and use osteopontin in medical formulations. Osteoporosis is a bone disease that results in weakened bones and a higher risk of bone fractures. Heavy drinking over time might affect the body's capacity to develop new bones and replace worn-out skeletal tissues. Due to the decreased bone density, this raises the risk of bone fractures and osteoporosis, driving demand for osteopontin in the coming years.
Osteopontin Market Report Highlights
Human segment will grow at rapid pace, due to the rise in researchers and pharmaceutical companies' efforts to create effective product formulations.
Medical segment accounted for the largest market share owing to the growing scientific studies specializing in pharmaceutical and medical therapy formulations.
North America is projected to register the largest growth rate, owing to the bone-related diseases in the region.
Europe is expected to have the fastest growth owing to companies following stringent regulations and building trust among the people in the region.
The global players include: Abnova, ACROBiosystems, Arla Foods Ingredients, BioLegend, MilliporeSigma & MyBioSource.
Polaris Market Research has segmented the osteopontin market report based on type, application, and region:
Osteopontin, Type Outlook (Revenue - USD Million, 2019 - 2032)
Osteopontin, Application Outlook (Revenue - USD Million, 2019 - 2032)
Osteopontin, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Osteopontin Market Insights
- 4.1. Osteopontin Market - Industry Snapshot
- 4.2. Osteopontin Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increased Research in Cancer Treatment
- 4.2.1.2. Rising Prevalence of Chronic Diseases
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Limited Awareness and Understanding
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Osteopontin Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Osteopontin Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Osteopontin, by Type, 2019-2032 (USD Million)
- 5.3. Human
- 5.3.1. Global Osteopontin Market, by Human, by Region, 2019-2032 (USD Million)
- 5.4. Rat
- 5.4.1. Global Osteopontin Market, by Rat, by Region, 2019-2032 (USD Million)
- 5.5. Cow
- 5.5.1. Global Osteopontin Market, by Cow, by Region, 2019-2032 (USD Million)
- 5.6. Others
- 5.6.1. Global Osteopontin Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Osteopontin Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Osteopontin Market, by Application, 2019-2032 (USD Million)
- 6.3. Food
- 6.3.1. Global Osteopontin Market, by Food, by Region, 2019-2032 (USD Million)
- 6.4. Medical
- 6.4.1. Global Osteopontin Market, by Medical, by Region, 2019-2032 (USD Million)
- 6.5. Others
- 6.5.1. Global Osteopontin Market, by Others, by Region, 2019-2032 (USD Million)
7. Global Osteopontin Market, by Geography
- 7.1. Key findings
- 7.2. Introduction
- 7.2.1. Osteopontin Market Assessment, By Geography, 2019-2032 (USD Million)
- 7.3. Osteopontin Market - North America
- 7.3.1. North America: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.3.2. North America: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.3.3. Osteopontin Market - U.S.
- 7.3.3.1. U.S.: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.3.3.2. U.S.: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.3.4. Osteopontin Market - Canada
- 7.3.4.1. Canada: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.3.4.2. Canada: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.4. Osteopontin Market - Europe
- 7.4.1. Europe: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.4.2. Europe: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.4.3. Osteopontin Market - UK
- 7.4.3.1. UK: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.4.3.2. UK: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.4.4. Osteopontin Market - France
- 7.4.4.1. France: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.4.4.2. France: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.4.5. Osteopontin Market - Germany
- 7.4.5.1. Germany: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.4.5.2. Germany: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.4.6. Osteopontin Market - Italy
- 7.4.6.1. Italy: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.4.6.2. Italy: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.4.7. Osteopontin Market - Spain
- 7.4.7.1. Spain: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.4.7.2. Spain: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.4.8. Osteopontin Market - Netherlands
- 7.4.8.1. Netherlands: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.4.8.2. Netherlands: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.4.9. Osteopontin Market - Russia
- 7.4.9.1. Russia: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.4.9.2. Russia: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.5. Osteopontin Market - Asia Pacific
- 7.5.1. Asia Pacific: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.5.2. Asia Pacific: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.5.3. Osteopontin Market - China
- 7.5.3.1. China: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.5.3.2. China: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.5.4. Osteopontin Market - India
- 7.5.4.1. India: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.5.4.2. India: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.5.5. Osteopontin Market - Malaysia
- 7.5.5.1. Malaysia: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.5.5.2. Malaysia: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.5.6. Osteopontin Market - Japan
- 7.5.6.1. Japan: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.5.6.2. Japan: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.5.7. Osteopontin Market - Indonesia
- 7.5.7.1. Indonesia: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.5.7.2. Indonesia: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.5.8. Osteopontin Market - South Korea
- 7.5.8.1. South Korea: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.5.8.2. South Korea: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.6. Osteopontin Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.6.2. Middle East & Africa: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.6.3. Osteopontin Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.6.3.2. Saudi Arabia: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.6.4. Osteopontin Market - UAE
- 7.6.4.1. UAE: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.6.4.2. UAE: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.6.5. Osteopontin Market - Israel
- 7.6.5.1. Israel: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.6.5.2. Israel: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.6.6. Osteopontin Market - South Africa
- 7.6.6.1. South Africa: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.6.6.2. South Africa: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.7. Osteopontin Market - Latin America
- 7.7.1. Latin America: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.7.2. Latin America: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.7.3. Osteopontin Market - Mexico
- 7.7.3.1. Mexico: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.7.3.2. Mexico: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.7.4. Osteopontin Market - Brazil
- 7.7.4.1. Brazil: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.7.4.2. Brazil: Osteopontin Market, by Type, 2019-2032 (USD Million)
- 7.7.5. Osteopontin Market - Argentina
- 7.7.5.1. Argentina: Osteopontin Market, by Application, 2019-2032 (USD Million)
- 7.7.5.2. Argentina: Osteopontin Market, by Type, 2019-2032 (USD Million)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Abnova
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. ACRO Biosystems
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Arla Foods Ingredients
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. BioLegend
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Bon Opus Biosciences
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. CHEMICON
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Creative Biomart
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Invitrogen
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. KAMIYA
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. LifeSpan Biosciences
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. MilliporeSigma
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. MyBioSource
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. NKMAX
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
- 9.14. OriGene
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
- 9.15. RD-SYSTEMS
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
- 9.16. Sino Biological
- 9.16.1. Company Overview
- 9.16.2. Financial Performance
- 9.16.3. Product Benchmarking
- 9.16.4. Recent Development